Hester Biosciences share price
You have to be logged in to add this to Watchlist.- ₹1,463.50(0.13%)March 10, 2026 15:29:56 PM IST
- NSE
- BSE
- Vol : 3.91 K (NSE + BSE)Last 20 day avg : 3.42 K
Hester Biosciences is trading 0.13% upper at Rs 1,463.50 as compared to its last closing price. Hester Biosciences has been trading in the price range of 1,463.50 & 1,427.80. Hester Biosciences has given -9.22% in this year & -7.04% in the last 5 days. Hester Biosciences has TTM P/E ratio 42.45 as compared to the sector P/E of -54.84.The company posted a net profit of 8.77 Crores in its last quarter.Listed peers of Hester Biosciences include Sun Pharmaceutical Industries (0.16%), Cipla (0.80%), Divi's Laboratories (0.56%).The Mutual Fund holding in Hester Biosciences was at 0.03% in 31 Dec 2022. The MF holding has decreased from the last quarter. The FII holding in Hester Biosciences was at 0.52% in 31 Dec 2025. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Mar 10, 2026, 10:06 AM UTC
- BetaHigh volatility1.26Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.68The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.47Annual dividends as a percentage of the stock price.
- PEG RatioIndicates undervaluation-3.48The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | Bullish | 1,810.55 | 0.16 | 4,34,401.36 | 36.24 | 5.77 | 0.92 | 0.50 |
| Cipla | Bearish | 1,335.70 | 0.80 | 1,08,316.22 | 22.95 | 3.87 | 0.87 | 0.81 |
| Divi's Laboratories | Neutral | 6,372.55 | 0.56 | 1,68,745.12 | 78.61 | 11.52 | 0.46 | 0.01 |
| Dr Reddy's Laboratories | Bullish | 1,315.70 | 2.28 | 1,10,056.96 | 18.63 | 3.14 | 0.63 | 2.34 |
| Torrent Pharmaceuticals | Bullish | 4,450.00 | 1.81 | 1,50,285.84 | 67.32 | 17.1 | 0.83 | 17.62 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-01-30 | Quarterly Results |
| 2025-11-12 | Quarterly Results |
| 2025-08-01 | Quarterly Results |
| 2025-05-09 | Audited Results & Final Dividend |
| 2025-01-30 | Quarterly Results |
- IndustryBiotechnology & Drugs
- ISININE782E01017
- BSE Code524669
- NSE CodeHESTERBIO
Hester Biosciences is trading at 1463.50 as on Tue Mar 10 2026 09:59:56. This is 0.13% upper as compared to its previous closing price of 1461.65.
The market capitalization of Hester Biosciences is 1244.43 Cr as on Tue Mar 10 2026 09:59:56.
The 52 wk high for Hester Biosciences is 2347.70 whereas the 52 wk low is 1246.75
Hester Biosciences can be analyzed on the following key metrics -
- TTM P/E: 42.45
- Sector P/E: -54.84
- Dividend Yield: 0.48%
- D/E ratio: -
Hester Biosciences reported a net profit of 27.49 Cr in 2025.
The Mutual Fund Shareholding was 0.03% at the end of 31 Dec 2022.